Exploiting human CD34+ stem cell-conditioned medium for tissue repair

Molecular Therapy

Volumn 22, Issue 1, 2014, Pages 149-159

  Mintz, Paul J ^a,b   Huang, Kai Wen ^c,d   Reebye, Vikash ^a   Nteliopoulos, Georgios ^a   Lai, Hong Shiee ^c,d   Sætrom, Pal ^e   Kasahara, Noriyuki ^f   Jensen, Steen ^a   Pai, Madhava ^a   Gordon, Myrtle Y A ^a   Marley, Stephen B ^a   Behan, Rosemary ^a   Spalding, Duncan R ^a   Haoudi, Abdelali ^b   Emara, Mohamed M ^b,g   Nicholls, Joanna ^a   Rossi, John J ^h   Habib, Nagy A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Cairo University   (Egypt)

^h CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; GROWTH FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HOXB4 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER INJURY; MALE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NANOG GENE; NONHUMAN; OCT4 GENE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SOX2 GENE; STEM CELL TRANSPLANTATION; TISSUE REPAIR; WOUND HEALING;

ANIMALIA;

ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DEATH; CELL LINE; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; LIVER REGENERATION; MALE; PRIMARY CELL CULTURE; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; RATS; REGENERATION; TRANSCRIPTOME; WOUND HEALING;

EID: 84891829209     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.194     Document Type: Article

References (52)

1. Weissman, IL (2000). Stem cells: Units of development, units of regeneration, and units in evolution. Cell 100: 157-168
2. Jaenisch, R and Young, R (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567-582
3. Fuchs, E, Tumbar, T and Guasch, G (2004). Socializing with the neighbors: Stem cells and their niche. Cell 116: 769-778
4. Slack, JM (2000). Stem cells in epithelial tissues. Science 287: 1431-1433
5. Janowska-Wieczorek, A, Majka, M, Ratajczak, J and Ratajczak, MZ (2001). Autocrine/ paracrine mechanisms in human hematopoiesis. Stem Cells 19: 99-107
6. Majka, M, Janowska-Wieczorek, A, Ratajczak, J, Ehrenman, K, Pietrzkowski, Z, Kowalska, MA et al. (2001). Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97: 3075-3085
7. Bonin-Debs, AL, Boche, I, Gille, H and Brinkmann, U (2004). Development of secreted proteins as biotherapeutic agents. Expert Opin Biol Ther 4: 551-558
8. Zhang, CC and Lodish, HF (2008). Cytokines regulating hematopoietic stem cell function. Curr Opin Hematol 15: 307-311
9. Abarbanell, AM, Coffey, AC, Fehrenbacher, JW, Beckman, DJ, Herrmann, JL, Weil, B et al. (2009). Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg 88: 1036-1043
10. Haylock, DN, To, LB, Dowse, TL, Juttner, CA and Simmons, PJ (1992). Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80: 1405-1412
11. Nervi, B, Link, DC and DiPersio, JF (2006). Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 99: 690-705
12. Orkin, SH and Zon, LI (2008). Hematopoiesis: An evolving paradigm for stem cell biology. Cell 132: 631-644
13. Kondo, M, Wagers, AJ, Manz, MG, Prohaska, SS, Scherer, DC, Beilhack, GF et al. (2003). Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 21: 759-806
14. Till, JE and McCulloch, EA (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213-222
15. Bianco, P, Riminucci, M, Gronthos, S and Robey, PG (2001). Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19: 180-192
16. Kaushansky, K (2006). Lineage-specific hematopoietic growth factors. N Engl J Med 354: 2034-2045
17. Pai, M, Zacharoulis, D, Milicevic, MN, Helmy, S, Jiao, LR, Levicar, N et al. (2008). Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103: 1952-1958
18. Gordon, MY, Levicar, N, Pai, M, Bachellier, P, Dimarakis, I, Al-Allaf, F et al. (2006). Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24: 1822-1830
19. Levicar, N, Pai, M, Habib, NA, Tait, P, Jiao, LR, Marley, SB et al. (2008). Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif (41 suppl. 1): 115-125
20. McNiece, I and Briddell, R (2001). Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol 29: 3-11
21. Suárez-Álvarez, B, López-Vázquez, A and López-Larrea, C (2012). Mobilization and homing of hematopoietic stem cells. Adv Exp Med Biol 741: 152-170
22. Mintz, PJ, Sætrom, P, Reebye, V, Lundbæk, MB, Lao, K, Rossi, JJ et al. (2012). MicroRNA-181a&z.ast; Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood. Mol Ther Nucleic Acids 1: E34
23. Jensen, LJ, Kuhn, M, Stark, M, Chaffron, S, Creevey, C, Muller, J et al. (2009). STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37(Database issue): D412-D416
24. Szklarczyk, D, Franceschini, A, Kuhn, M, Simonovic, M, Roth, A, Minguez, P et al. (2011). The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(Database issue): D561-D568
25. Chen, LH, Hsu, CY and Weng, CF (2006). Involvement of P53 and Bax/Bad triggering apoptosis in thioacetamide-induced hepatic epithelial cells. World J Gastroenterol 12: 5175-5181
26. Huang, KW, Huang, YC, Tai, KF, Chen, BH, Lee, PH and Hwang, LH (2008). Dual therapeutic effects of interferon-alpha gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis. Mol Ther 16: 1681-1687
27. Mimeault, M and Batra, SK (2012). Great promise of tissue-resident adult stem/ progenitor cells in transplantation and cancer therapies. Adv Exp Med Biol 741: 171-186
28. Horie, N, Pereira, MP, Niizuma, K, Sun, G, Keren-Gill, H, Encarnacion, A et al. (2011). Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29: 274-285
29. Ren, X, Carpenter, A, Hogaboam, C and Colletti, L (2003). Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol 163: 563-570
30. Kuboki, S, Shin, T, Huber, N, Eismann, T, Galloway, E, Schuster, R et al. (2008). Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology 48: 1213-1223
31. Hogaboam, CM, Bone-Larson, CL, Steinhauser, ML, Lukacs, NW, Colletti, LM, Simpson, KJ et al. (1999). Novel CXCR2-dependent liver regenerative qualities of ELRcontaining CXC chemokines. FASEB J 13: 1565-1574
32. Luster, AD (1998). Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445
33. Mantovani, A, Bonecchi, R and Locati, M (2006). Tuning inflammation and immunity by chemokine sequestration: Decoys and more. Nat Rev Immunol 6: 907-918
34. Gillitzer, R and Goebeler, M (2001). Chemokines in cutaneous wound healing. J Leukoc Biol 69: 513-521
35. Lin, Z, Rios, HF, Volk, SL, Sugai, JV, Jin, Q and Giannobile, WV (2011). Gene expression dynamics during bone healing and osseointegration. J Periodontol 82: 1007-1017
36. Nedeau, AE, Bauer, RJ, Gallagher, K, Chen, H, Liu, ZJ and Velazquez, OC (2008). A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 314: 2176-2186
37. Zaja-Milatovic, S and Richmond, A (2008). CXC chemokines and their receptors: A case for a significant biological role in cutaneous wound healing. Histol Histopathol 23: 1399-1407
38. Badr, G, Badr, BM, Mahmoud, MH, Mohany, M, Rabah, DM and Garraud, O (2012). Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1a, MIP-2, KC, CX3CL1 and TGF-ß in wounded tissue. BMC Immunol 13: 32
39. Quandt, J and Dorovini-Zis, K (2004). The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells. J Neuropathol Exp Neurol 63: 350-362
40. Deshmane, SL, Kremlev, S, Amini, S and Sawaya, BE (2009). Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29: 313-326
41. Yamashita, U and Kuroda, E (2002). Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 22: 105-114
42. Tymen, SD, Rojas, IG, Zhou, X, Fang, ZJ, Zhao, Y and Marucha, PT (2013). Restraint stress alters neutrophil and macrophage phenotypes during wound healing. Brain Behav Immun 28: 207-217
43. Broughton, SE, Dhagat, U, Hercus, TR, Nero, TL, Grimbaldeston, MA, Bonder, CS et al. (2012). The GM-CSF/IL-3/IL-5 cytokine receptor family: From ligand recognition to initiation of signaling. Immunol Rev 250: 277-302
44. Karimbux, NY, Saraiya, VM, Elangovan, S, Allareddy, V, Kinnunen, T, Kornman, KS et al. (2012). Interleukin-1 gene polymorphisms and chronic periodontitis in adult whites: A systematic review and meta-analysis. J Periodontol 83: 1407-1419
45. Metz, CN (2003). Fibrocytes: A unique cell population implicated in wound healing. Cell Mol Life Sci 60: 1342-1350
46. Ishida, Y, Kondo, T, Kimura, A, Matsushima, K and Mukaida, N (2006). Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 176: 5598-5606
47. Rennekampff, HO, Hansbrough, JF, Kiessig, V, Doré, C, Sticherling, M and Schröder, JM (2000). Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 93: 41-54
48. Schraufstatter, IU, Trieu, K, Zhao, M, Rose, DM, Terkeltaub, RA and Burger, M (2003). IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol 171: 6714-6722
49. Saraiva, M and O'Garra, A (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181
50. Wynn, TA (2003). IL-13 effector functions. Annu Rev Immunol 21: 425-456
51. Muller, M, Trocme, C, Lardy, B, Morel, F, Halimi, S and Benhamou, PY (2008). Matrix metalloproteinases and diabetic foot ulcers: The ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 25: 419-426
52. Rho, SB, Chung, BM and Lee, JH (2007). TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF. J Cell Biochem 101: 57-67